Sierra Summit Advisors LLC Catalyst Pharmaceuticals, Inc. Transaction History
Sierra Summit Advisors LLC
- $562 Billion
- Q2 2025
A detailed history of Sierra Summit Advisors LLC transactions in Catalyst Pharmaceuticals, Inc. stock. As of the latest transaction made, Sierra Summit Advisors LLC holds 26,715 shares of CPRX stock, worth $544,718. This represents 0.1% of its overall portfolio holdings.
Number of Shares
26,715
Previous 26,478
0.9%
Holding current value
$544,718
Previous $642 Million
9.71%
% of portfolio
0.1%
Previous 0.14%
Shares
2 transactions
Others Institutions Holding CPRX
# of Institutions
386Shares Held
103MCall Options Held
0Put Options Held
277K-
Black Rock Inc. New York, NY18.7MShares$381 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA8.77MShares$179 Million0.0% of portfolio
-
State Street Corp Boston, MA5.48MShares$112 Million0.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny3.25MShares$66.3 Million0.1% of portfolio
-
Morgan Stanley New York, NY3.18MShares$64.9 Million0.0% of portfolio
About CATALYST PHARMACEUTICALS, INC.
- Ticker CPRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 102,820,000
- Market Cap $2.1B
- Description
- Catalyst Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies for people with rare debilitating, chronic neuromuscular, and neurological diseases in the United States. It offers Firdapse, an amifampridine phosphate tablets for the treatment of patients with lambert-eaton myasthe...